Ronald K. Yamamoto
Oprichter bij Oxular Ltd.
Profiel
Ronald K.
Yamamoto was the founder of Vitaphore Corp.
(founded in 1985) and Oxular Ltd.
(founded in 2014), where he held the titles of VP, Chief Executive & Scientific Officer and Chief Scientific Officer & Director, respectively.
He previously held the position of President & Chief Executive Officer at POINT Biomedical Corp.
and served as a Director at Biocept, Inc., iScience Interventional Corp., and Halscion, Inc. Mr. Yamamoto received his graduate degree from the University of Southern California and Clemson University, and his undergraduate degree from the California Institute of Technology.
Actieve functies van Ronald K. Yamamoto
| Bedrijven | Functie | Begin |
|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Oprichter | 01-01-2014 |
Eerdere bekende functies van Ronald K. Yamamoto
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOCEPT, INC. | Directeur/Bestuurslid | - |
Halscion, Inc.
 Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Directeur/Bestuurslid | - |
| Vitaphore Corp. | Oprichter | - |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | President | - |
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ronald K. Yamamoto
| California Institute of Technology | Undergraduate Degree |
| Clemson University | Graduate Degree |
| University of Southern California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOCEPT, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
| Vitaphore Corp. | |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
Halscion, Inc.
Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
